Longevity & Mitochondrial Research Preliminary

Pinealon

Tripeptide (Glu-Asp-Arg) from pineal gland. Russian research program studied it for neuroprotective and longevity properties.

pinealneuroprotectivelongevitymelatonincognition
Half-life
Short; estimated 1–2 hours
SKUs Available
2
Evidence Level
Preliminary
Mechanism of Action

Proposed gene-regulatory peptide that may influence expression of antioxidant enzymes and neuronal protective pathways.

Published Research Ranges & Study Context

Studies have administered: 1–10mg daily cycles in published research

Important Research Framing These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings

Russian clinical studies reported improvements in cognitive function markers and melatonin regulation in aging subjects.

Preliminary Primarily preclinical + case reports
Side Effects Observed in Research

Limited data; injection site reactions; generally well-tolerated in published studies

Available Configurations (SKU Reference)
PI10 PI20
Compounds Studied in Combination

These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.

Want a Complete Research Monograph?

Our AI can generate a 2,000+ word deep-dive on Pinealon — including full clinical trial summaries, pharmacokinetics, and research frontiers.

Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.